USD 5.28
(6.45%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 119.35 Million USD | -3.59% |
2022 | 123.79 Million USD | -6.43% |
2021 | 132.3 Million USD | 56.07% |
2020 | 84.77 Million USD | -15.74% |
2019 | 100.6 Million USD | 69.76% |
2018 | 59.26 Million USD | 59162.0% |
2017 | 100 Thousand USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 175 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 110.98 Million USD | -2.88% |
2024 Q1 | 116.22 Million USD | -2.62% |
2023 Q4 | 119.35 Million USD | -4.53% |
2023 Q3 | 125.01 Million USD | 0.22% |
2023 FY | 119.35 Million USD | -3.59% |
2023 Q2 | 124.74 Million USD | 1.96% |
2023 Q1 | 122.35 Million USD | -1.16% |
2022 FY | 123.79 Million USD | -6.43% |
2022 Q4 | 123.79 Million USD | -5.3% |
2022 Q2 | 131.61 Million USD | 1.09% |
2022 Q3 | 130.71 Million USD | -0.68% |
2022 Q1 | 130.19 Million USD | -1.59% |
2021 Q4 | 132.3 Million USD | 18.04% |
2021 FY | 132.3 Million USD | 56.07% |
2021 Q1 | 99.17 Million USD | 16.99% |
2021 Q2 | 112.2 Million USD | 13.14% |
2021 Q3 | 112.08 Million USD | -0.11% |
2020 Q3 | 114.73 Million USD | -0.5% |
2020 FY | 84.77 Million USD | -15.74% |
2020 Q4 | 84.77 Million USD | -26.11% |
2020 Q2 | 115.31 Million USD | 4.82% |
2020 Q1 | 110 Million USD | 9.34% |
2019 FY | 100.6 Million USD | 69.76% |
2019 Q4 | 100.6 Million USD | -0.24% |
2019 Q3 | 100.84 Million USD | 11.75% |
2019 Q2 | 90.24 Million USD | 2.47% |
2019 Q1 | 88.06 Million USD | 48.6% |
2018 FY | 59.26 Million USD | 59162.0% |
2018 Q3 | 700 Thousand USD | 47.37% |
2018 Q4 | 59.26 Million USD | 8366.0% |
2018 Q2 | 475 Thousand USD | 58.33% |
2018 Q1 | 300 Thousand USD | 200.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q4 | 100 Thousand USD | 0.0% |
2017 FY | 100 Thousand USD | 0.0% |
2016 Q4 | - USD | -100.0% |
2016 FY | - USD | -100.0% |
2016 Q2 | 175 Thousand USD | 0.0% |
2016 Q3 | 300 Thousand USD | 71.43% |
2015 FY | 175 Thousand USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
ANI Pharmaceuticals, Inc. | 315.32 Million USD | 62.15% |
Aquestive Therapeutics, Inc. | 98.82 Million USD | -20.774% |
Collegium Pharmaceutical, Inc. | 674.28 Million USD | 82.3% |
Cosmos Health Inc. | 12.42 Million USD | -860.652% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -11452.538% |
Esperion Therapeutics, Inc. | 540.94 Million USD | 77.937% |
Cronos Group Inc. | 2.53 Million USD | -4598.973% |
Incannex Healthcare Limited | 373 Thousand USD | -31897.587% |
Kala Pharmaceuticals, Inc. | 36.32 Million USD | -228.582% |
Lifecore Biomedical, Inc. | 130.36 Million USD | 8.445% |
Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -199460.252% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -18046.585% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -18046.585% |
SCYNEXIS, Inc. | 15.08 Million USD | -691.452% |
Safety Shot Inc | 1.54 Million USD | -7605.165% |
Theratechnologies Inc. | 58.96 Million USD | -102.4% |
Alpha Teknova, Inc. | 30.45 Million USD | -291.854% |
Universe Pharmaceuticals INC | 5.48 Million USD | -2076.962% |
Pacira BioSciences, Inc. | 586.04 Million USD | 79.634% |
Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -19530.099% |
Dynavax Technologies Corporation | 256.91 Million USD | 53.544% |
Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 83.32% |
Radius Health, Inc. | 365.31 Million USD | 67.329% |
China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -4408.141% |
Alvotech | 1.07 Billion USD | 88.902% |
Intra-Cellular Therapies, Inc. | 16.93 Million USD | -604.635% |
SIGA Technologies, Inc. | 1.46 Million USD | -8052.341% |
Shineco, Inc. | 29.65 Million USD | -302.445% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Journey Medical Corporation | 17.73 Million USD | -573.158% |
Petros Pharmaceuticals, Inc. | 8.27 Million USD | -1342.031% |
Embecta Corp. | 1.63 Billion USD | 92.716% |
Harrow Health, Inc. | 190.5 Million USD | 37.349% |
Procaps Group, S.A. | 285.93 Million USD | 58.259% |
Biofrontera Inc. | 5.39 Million USD | -2110.613% |
DURECT Corporation | 20.74 Million USD | -475.296% |
PainReform Ltd. | 86 Thousand USD | -138680.233% |
Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -187.406% |
OptiNose, Inc. | 131.74 Million USD | 9.41% |
RedHill Biopharma Ltd. | 1.17 Million USD | -10074.799% |
Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -547.644% |
ProPhase Labs, Inc. | 21.38 Million USD | -458.237% |
Phibro Animal Health Corporation | 525.45 Million USD | 77.286% |
Procaps Group S.A. | 285.93 Million USD | 58.259% |
TherapeuticsMD, Inc. | 8 Million USD | -1390.956% |
Viatris Inc. | 18.12 Billion USD | 99.341% |
Rockwell Medical, Inc. | 13.43 Million USD | -788.094% |
Aytu BioPharma, Inc. | 15.12 Million USD | -688.889% |
Tilray Brands, Inc. | 387.31 Million USD | 69.185% |
PetIQ, Inc. | 468.3 Million USD | 74.514% |
Talphera, Inc. | - USD | -Infinity% |
Neurocrine Biosciences, Inc. | 428.4 Million USD | 72.14% |
Alimera Sciences, Inc. | 67.39 Million USD | -77.081% |
Assertio Holdings, Inc. | 40.91 Million USD | -191.726% |
Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -10872.847% |
Avadel Pharmaceuticals plc | 35.38 Million USD | -237.302% |
Hempacco Co., Inc. | 13.72 Million USD | -769.62% |
Alvotech | 1.07 Billion USD | 88.902% |
Lantheus Holdings, Inc. | 616.94 Million USD | 80.655% |
Kamada Ltd. | 8.74 Million USD | -1264.169% |
Currenc Group, Inc. | 31.94 Million USD | -273.63% |
Indivior PLC | 281.6 Million USD | 57.617% |
Evoke Pharma, Inc. | 5 Million USD | -2287.02% |
Flora Growth Corp. | 3.67 Million USD | -3150.3% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -11452.538% |
Evolus, Inc. | 126.54 Million USD | 5.686% |
HUTCHMED (China) Limited | 86.13 Million USD | -38.569% |
Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 80.862% |
Akanda Corp. | 3.99 Million USD | -2884.677% |